[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366112-105":59,"doc-detail-366112-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","kshv-reprograms-host-rna-splicing-via-fam50a-to-activate-stat3-and-drive-oncogenic-cellular-transformation","KSHV reprograms host RNA splicing via FAM50A to activate STAT3 and drive oncogenic cellular transformation","","RNA alternative splicing orchestrates post-transcriptional gene regulation and is deeply tied to cancer. Kaposi’s sarcoma-associated herpesvirus (KSHV) drives malignancies and, in this work, a CRISPR-Cas9 screen in matched primary rat mesenchymal stem cells and KSHV-transformed derivatives identified splicing factors that govern KSHV-induced transformation. Transcriptomic sequencing revealed 131 differentially alternatively spliced transcripts dominated by exon skipping, enriched in vascular permeability, metabolic programs, and ERK1/2 signaling. Viral mutant and LANA overexpression studies linked alternative splicing regulation to latent gene functions. Among candidate factors, FAM50A proved essential: knockout or knockdown disrupted splicing, inhibited KSHV-driven proliferation, transformation, and tumorigenesis, and altered SHP2 splicing to sustain STAT3 activation via reduced STAT3 Y705 phosphorylation in transformed cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/kshv-reprograms-host-rna-splicing-via-fam50a-to-activate-stat3-and-drive-oncogenic-cellular-transformation/366112/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/kshv-reprograms-host-rna-splicing-via-fam50a-to-activate-stat3-and-drive-oncogenic-cellular-transformation/366112.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What key process does the study focus on in cancer development?","Question",{"text":112,"@type":113},"The study focuses on RNA alternative splicing as a fundamental cellular process linked to cancer development and dysregulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did researchers identify splicing factors involved in KSHV transformation?",{"text":117,"@type":113},"They used a CRISPR-Cas9 screening approach in matched primary rat mesenchymal stem cells and KSHV-transformed cells to identify key splicing factors.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is FAM50A important for KSHV-driven oncogenic transformation?",{"text":121,"@type":113},"FAM50A knockout or knockdown disrupted splicing and significantly inhibited KSHV-driven proliferation, cellular transformation, and tumorigenesis, partly by altering SHP2 splicing to affect STAT3 signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366112,1790196894,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","| Virology | Research Article  \nKSHV reprograms host RNA splicing via FAM50A to activate STAT3 and drive oncogenic cellular transformation  \nShenyu Sun,1,2,3 Ling Ding,1,2 Karla Paniagua,4 Xian Wang,1,2 Yufei Huang,1,5,6 Mario A. Flores,4 Shou-Jiang Gao1,2,3 AUTHOR AFFILIATIONS See affiliation list on p. 20.  \nABSTRACT RNA alternative splicing is a fundamental cellular process implicated in cancer development. Kaposi’s sarcoma-associated herpesvirus (KSHV), the etiological agent of multiple human malignancies, including Kaposi’s sarcoma (KS), remains a significant concern, particularly in AIDS patients. A CRISPR-Cas9 screening of matched primary rat mesenchymal stem cells (MM) and KSHV-transformed MM cells (KMM) identified key splicing factors involved in KSHV-induced cellular transformation. To elucidate the mechanisms by which KSHV-driven splicing reprogramming mediates cellular transformation, we performed transcriptomic sequencing, identifying 131 differentially alternative spliced transcripts, with exon skipping as the predominant event. Notably, these transcripts were enriched in vascular permeability, multiple metabolic pathways, and ERK1/2 signaling cascades, which play key roles in KSHVinduced oncogenesis. Further analyses of cells infected with KSHV mutants lacking latent genes, including vFLIP, vCyclin, and viral miRNAs, as well as cells overexpressing LANA, revealed their involvement in alternative splicing regulation. Among the identified splicing factors, FAM50A, a component of the spliceosome complex C, was found to be crucial for KSHV-mediated transformation. FAM50A knockout resulted indistinct splicing profiles in both MM and KMM cells and significantly inhibited KSHVdriven proliferation, cellular transformation, and tumorigenesis. Consistently, FAM50Aknockdown suppressed the proliferation of PEL cells. Mechanistically, FAM50A knockout altered SHP2 splicing, promoting an isoform with enhanced enzymatic activity that led to reduced STAT3 Y705 phosphorylation in KMM cells. These findings reveal a novel paradigm in which KSHV hijacks host splicing machinery, specifically FAM50A-mediated SHP2 splicing, to sustain STAT3 activation and drive oncogenic transformation.  \nIMPORTANCE Kaposi’s sarcoma-associated herpesvirus (KSHV) causes cancers such as Kaposi’s sarcoma, particularly in AIDS patients. This study uncovers how KSHV hijacksa fundamental cellular process called RNA splicing to promote cancer development. We identified key splicing events that alter critical pathways involved in vascular permeability, metabolism, and oncogenic signaling, particularly ERK1/2 and STAT3 . A specific protein, FAM50A, was found to be essential for KSHV-driven cancerous transformation. Removing FAM50A disrupted splicing, weakening cancer-promoting signals. These findings provide new insights into how viruses manipulate host cells to drive cancer and highlight RNA splicing as a potential target for future therapies.  \nKEYWORDS Kaposi’s sarcoma (KS), Kaposi’s sarcoma-associated herpesvirus, KSHV, RNA splicing, FAM50A, SHP2, STAT3 activation, cellular transformation  \nA lternative splicing is a fundamental post-transcriptional mechanism that regulates  \ngene expression in eukaryotic cells (1) . It relies on the precise recognition of splice sites and selective intron removal, orchestrated by the spliceosome, a dynamic ribonucleoprotein (RNP) complex consisting of five small nuclear RNAs (snRNAs; U1, U2,  \nEditor Thomas Shenk, Princeton University, Princeton, New Jersey, USA  \nAddress correspondence to Shou-Jiang Gao, [gaos8@upmc.edu](gaos8@upmc.edu).  \nauthors declare conflict of interest  \nU4, U5, and U6) and numerous associated proteins (2) . Through alternative splicing, a single precursor mRNA (pre-mRNA) can be differentially spliced to generate multiple mRNA isoforms, significantly expanding the proteomic diversity of eukaryotic organisms (2) . This process is essential for the functional complexity of the mammalian proteome, all","cbCaiel6t5r2QKUk","https://ap.wps.com/l/cbCaiel6t5r2QKUk","pdf",4685348,23,"English","# Abstract\n# Importance\n# Background and Rationale","[{\"question\":\"What key process does the study focus on in cancer development?\",\"answer\":\"The study focuses on RNA alternative splicing as a fundamental cellular process linked to cancer development and dysregulation.\"},{\"question\":\"How did researchers identify splicing factors involved in KSHV transformation?\",\"answer\":\"They used a CRISPR-Cas9 screening approach in matched primary rat mesenchymal stem cells and KSHV-transformed cells to identify key splicing factors.\"},{\"question\":\"Why is FAM50A important for KSHV-driven oncogenic transformation?\",\"answer\":\"FAM50A knockout or knockdown disrupted splicing and significantly inhibited KSHV-driven proliferation, cellular transformation, and tumorigenesis, partly by altering SHP2 splicing to affect STAT3 signaling.\"}]","KSHV reprograms host RNA splicing via FAM50A to activate STAT3 and drive oncogenic cellular transformation | PDF",1790163870,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a47b2048e0cf9b3bc13184b54db8377c.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abe56d1b87589eac41bfd0413dbd269a.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/598e6aba9ebb22de656f45eac5c11b86.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c8e0440b77b69e6ed8c2c6c0710894c.webp",980,1311]